Ir para o conteúdo principal

United States Últimas notícias

Todas as matérias desta categoria, das mais recentes às mais antigas.

Grafa
Health

Citius Oncology reports positive Phase 1 data for LYMPHIR-Pembrolizumab combo

Citius Oncology (NASDAQ:CTOR) reported positive topline results on Tuesday from an investigator-initiated Phase 1 clinical trial evaluating its flagship immunotherapy, LYMPHIR (denileukin diftitox-cxdl), in combination with Merck’s pembrolizumab (Keytruda).

Leia mais: Citius Oncology reports positive Phase 1 data for LYMPHIR-Pembrolizumab combo
Grafa
Technology

Anthropic warns of ‘billions’ in lost revenue over Pentagon security blacklist

Anthropic PBC warned a federal judge on Tuesday that it faces the potential loss of billions of dollars in revenue this year due to the Trump administration’s decision to label the artificial intelligence startup a national security risk.

Leia mais: Anthropic warns of ‘billions’ in lost revenue over Pentagon security blacklist